Screener
Zevra Therapeutics, Inc. ZVRA Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Zevra Therapeutics, Inc.’s reported figures.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
FAQ
- What is Zevra Therapeutics, Inc.'s free cash flow?
- Zevra Therapeutics, Inc. (ZVRA) reported free cash flow of $16.82M in Q2 2026.
- How has Zevra Therapeutics, Inc.'s free cash flow changed year-over-year?
- Zevra Therapeutics, Inc.'s free cash flow increased by 540.9% year-over-year, from -$3.81M to $16.82M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s free cash flow?
- Over 2 years (2022 to 2024), Zevra Therapeutics, Inc.'s free cash flow has grown at a 92.4% compound annual growth rate (CAGR), from -$18.81M to -$69.67M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Zevra Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude